http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007030589-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_73ba6d24eb161879ca6fdc63e9f09feb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e99a62ff108e8c7520d279f28c77c5c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a54f057c50fbf69e614b3898c53c7c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ab2b97b960a789112a8a911dc6cebeb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a348bd3229ad8a917bb8ebf29b3cf39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f515608ba8866f2b3757f259b7c1cf7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_698196835fd6c1ade076236d4d8d63ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7c43f3b9547f4bbdd93a8b51214bd2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f7019dc9df39e6e323db876745dc433
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_266ea718e0a8716477d68da1380d48b5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-286
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
filingDate 2006-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5df0eea3dbe71112e6f2cd0671d69895
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d69309aca3ed4ba57e7fda9557a1d8b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10391ae897d02ee4eb5f033149060dca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c328f9250025bb2562e65a88231fd6b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_320bd195af95090ea1d7ab6d5a5edced
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3423e54c7af6c504b47d440361ff32bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7b7081cf745e519ebe649c7af29d8f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91d458ac96a7229bf100e96cced5c250
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb99046e8b01a90a07c21a6b8b1d912e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6200cdc8181797add7b4367281b5f36a
publicationDate 2007-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007030589-A3
titleOfInvention Pharmaceutical dosage forms and compositions comprising lecoztan
abstract The invention relates to, for example, novel formulations and methods for the delivery of 4-cyano-N-{(2R)-2-[4-(2,3-dihydro-benzo[l ,4]dioxin-5-yl)-piperazin-l -yl]-propyl}-N- pyridin-2-yl-benzamide, pharmaceutically acceptable salts thereof, structurally related compounds and/or metabolites; as well as to use of these formulations and methods for treating disease.
priorityDate 2005-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005044222-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006093853-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005092307-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0226214-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10116877
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228950512
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230441545
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69076489

Total number of triples: 66.